Glimison-M 1 Tablet PR
By Glimison-M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Unison Pharmaceuticals Pvt Ltd
Unison Pharmaceuticals Pvt. Ltd., UNISON HOUSE Near Prernatirth Derasar, Near Ratnadeep-II, Satellite, Jodhpur, Ahmedabad-380 015, GUJARAT, INDIA.

Expires on or after
September, 2027

liver
When it comes to the use of Glimison-M 1 Tablet PR, caution is advised for individuals with liver disease. It may be necessary to adjust the dosage of Glimison-M 1 Tablet PR in such cases, so it is crucial to consult with your doctor before starting the medication. Typically, Glimison-M 1 Tablet PR is initiated at a low dose for patients with mild to moderate liver disease. However, it is not recommended for use in individuals with severe liver disease. It is important to follow your healthcare provider's guidance closely to ensure safe and effective use of this medication.

kidney
Glimison-M 1 Tablet PR should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for guidance.

alcohol
It is not safe to mix alcohol with Glimison-M 1 Tablet PR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Glimison-M 1 Tablet PR to ensure safety.

pregnancy
Glimison-M 1 Tablet PR may be unsafe during pregnancy. Limited human studies suggest risks to the developing baby. Consult your doctor for a careful assessment of benefits and risks before using this medication.

breastfeeding
Caution Glimison-M 1 Tablet PR is not safe to use while breastfeeding as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹39.15
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024